stockrow
Friday 6 November 2026
Export CDIO’s income statement to Excel — free account
Cardio Diagnostics Holdings, Inc.
CDIO Healthcare Biotechnology
Cardio Diagnostics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14,800.00, down 57.6% from fiscal 2024.
- Revenue
- +23.8%
- EPS
- +47.4%
- Free cash flow
- +2.59%
Quarter to September 2026, against a year earlier
1.65
0.03
−1.79%
Follow CDIO
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '17 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 4 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
318.47 | 1,036.37 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(3.61) | 9.31 | 3.25 | (1.98) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(4.17) | 2.25 | (16.51) | (1.56) | 29.94 | — |
P/Operating CF |
(3.48) | (25.98) | (34.58) | (1.09) | (7,958.34) | — |
Beneish M-Score |
(3.53) | (2.27) | — | — | — | — |
P/B ratio |
0.68 | 3.78 | 19.71 | 0.79 | 3,506.47 | — |
Price to Tangible BV |
0.68 | 3.79 | 19.85 | 0.80 | 3,506.47 | — |
EV/Sales |
(24.52) | 812.09 | 0.00 | 0.00 | 0.00 | — |
EV/EBITDA |
0.06 | 0.00 | 0.00 | 0.16 | 0.00 | — |
EV/Operating CF |
0.06 | (5.68) | (10.05) | 0.14 | 0.00 | — |
EV/FCF |
0.06 | (5.44) | (9.12) | 0.14 | 0.00 | — |
Quick Ratio |
8.46 | 12.42 | 1.53 | 2.11 | 15.15 | — |
Current Ratio |
9.79 | 13.92 | 3.29 | 3.02 | 23.70 | — |
Net Debt/EBITDA |
0.84 | 0.97 | 0.18 | 0.91 | 0.85 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.88 | 0.60 | 0.68 | 1.09 | 0.94 | — |
Capex/Depreciation |
(0.47) | (0.78) | (5.16) | 0.00 | 0.00 | — |
Interest Coverage |
(438.11) | (449.78) | (1.08) | — | (1,240.80) | — |
| (78.62%) | (133.97%) | (230.77%) | (173.60%) | 0.00% | — | |
| (70.70%) | (111.20%) | (156.40%) | (126.80%) | (112.60%) | — | |
ROIC |
(217.55%) | (302.18%) | (270.31%) | (1,543.33%) | (69.83%) | — |
Return on Tangible Assets |
(108.02%) | (94.92%) | (335.54%) | (118.36%) | (80.61%) | — |
Average Days of Receivables |
199.76 | 194.53 | 106.73 | 0.00 | 365.00 | — |
Research and Development Expense of Revenue |
4,332.43% | 653.30% | 849.12% | 4,040.00% | 3,500.00% | — |
Selling, General and Administrative Expense of Revenue |
39,138.51% | 23,361.32% | 41,492.40% | 449,300.00% | 63,766.67% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.01 | 0.05 | 0.00 |
Share Based Compensation of Revenue |
744.59% | 7,424.64% | 7,481.29% | 0.00% | 6,666.67% | — |
Graham Net Nets |
1.08 | 0.21 | 0.02 | 1.16 | (0.03) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(137.27%) | (39.13%) | (23.97%) | (137.37%) | (3.97%) | — |
Free Cash Flow Yield |
(124.63%) | (14.40%) | (10.72%) | (150.07%) | 0.00% | — |
Revenue per Share |
0.01 | 0.04 | 0.04 | 0.01 | 0.02 | — |
Operating CF per Share |
(3.27) | (5.57) | (13.43) | (49.52) | (15.12) | — |
Capex per Share |
(0.11) | (0.24) | (1.36) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(3.38) | (5.81) | (14.79) | (49.52) | (15.12) | — |
Cash per Share |
2.92 | 8.74 | 3.04 | 40.05 | 13.25 | — |
Shareholders Equity per Share |
3.98 | 10.67 | 7.00 | 41.85 | 27.60 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
3.98 | 10.67 | 7.00 | 41.85 | 27.60 | — |
Free Cash Flow |
(5.91) | (5.21) | (6.25) | (5.09) | (0.59) | — |
Working Capital |
5.32 | 8.16 | 1.92 | 3.94 | 0.77 | — |
Capital Expenditures |
(0.19) | (0.21) | (0.58) | (0.08) | (0.11) | — |
Net Current Asset Value |
5.13 | 7.73 | 1.26 | 3.94 | 0.77 | — |
EV/EBIT |
0.06 | 0.00 | 0.00 | 0.16 | 0.00 | — |
Capex to Sales |
12.66 | 6.15 | 33.67 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||
Depreciation/Fixed assets |
0.57 | 0.41 | 0.20 | 0.00 | 0.00 | — |
Cash ROIC |
(48.94%) | (29.96%) | (147.30%) | (60.47%) | (37.02%) | — |
Accounts Receivable Turnover |
1.11 | 2.96 | 5.80 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | — | — | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — |
Average Receivables |
0.01 | 0.01 | 0.00 | — | — | — |
Average Payables |
0.09 | 0.17 | 0.67 | 0.57 | — | — |
Average Assets |
9.19 | 7.54 | 5.36 | 3.68 | 0.55 | — |
Average Common Equity |
8.27 | 6.26 | 3.63 | 2.68 | — | — |
Columns are period end dates · fundamentals updated 6 Nov 2026